Form D · Biotechnology

Patara Pharma, LLC

San Diego, CA · CIK 0001598105

Offering snapshot reported Oct 13, 2016 · SEC filing

Reported sold
$6M
Offering amount: $6M
Investors reported
37
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 30, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 13, 2016Initial$6,000,000No comparison37SEC filing
Oct 14, 2015Amendment$24,000,000$13,450,000vs Sep 15, 201449SEC filing
Sep 15, 2014Initial$10,550,000No comparison34SEC filing
Feb 4, 2014Amendment$1,802,170$2,170vs Jan 24, 201428SEC filing
Jan 24, 2014Initial$1,800,000No comparison22SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-272452

Source: Form D, filed Oct 13, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Bernoulli Pharma Holdings, Llc Director, Promoter
William M. Gerhart Director, Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
11455 El Camino Real, Suite 460
San Diego, CA, 92130